The company, which is conducting the trial in the US, says the drug has already shown strong potential against the Covid-19 virus and other viruses in laboratory experiments.
Mikael Dolsten, Pfizer’s chief scientific officer, has said that: “Given the way that SARS-CoV-2 is mutating and the continued global impact of Covid-19, it appears likely that it will be critical to have access to therapeutic options both now and beyond the pandemic.”
Whitehall mandarins are reportedly seeking senior figures from private industry to head the new task force, with no appointments yet agreed.
The set-up would follow the model of the Vaccines Taskforce, which was led by biochemist turned venture capitalist Kate Bingham, who successfully secured access agreements to six different vaccines across four formats.
The government source said Ms Bingham is not in the frame to serve on the new anti-virals taskforce.
Zeen is a next generation WordPress theme. It’s powerful, beautifully designed and comes with everything you need to engage your visitors and increase conversions.